drugset / Trial / NCT01184456
A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Improvement in the rate of bacterial translocation may lead to a decrease in a chronic inflammatory response thereby decreasing CD4 destruction and HIV proliferation. By the addition of probiotics we hope to show a reduction in LPS leading to a decrease in chronic inflammation and therefore an improvement in immune markers.
Timeline
- Start
- 2010-08
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bacillus coagulans | Other / unclassified | 2e+09 unknown | — |